ArticleJournal of clinical medicine2020

Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with "Treat-and-Extend" Regimen-Its Usefulness and Problems.

Shinichiro Chujo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.